Page last updated: 2024-09-05

3-o-methyl-6-fluoro-dopa and Atrophy

3-o-methyl-6-fluoro-dopa has been researched along with Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aalto, S; Brück, A; Forsback, S; Jokinen, P; Parkkola, R; Rinne, JO	1

Other Studies

1 other study(ies) available for 3-o-methyl-6-fluoro-dopa and Atrophy

Article	Year
Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism & related disorders, 2009, Volume: 15, Issue:2 Topics: Aged; Analysis of Variance; Atrophy; Caudate Nucleus; Cognition Disorders; Dihydroxyphenylalanine; Dopamine; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Statistics, Nonparametric	2009

Article

Year

Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.

Parkinsonism & related disorders, 2009, Volume: 15, Issue:2

Topics: Aged; Analysis of Variance; Atrophy; Caudate Nucleus; Cognition Disorders; Dihydroxyphenylalanine; Dopamine; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Statistics, Nonparametric

2009